Houston (1)

Recurrent Glioblastoma Multiforme(GBM) (1)

Recruiting (1)

phase 1/phase 2 (1)

Accendatech USA Inc. (1)

Avance Clinical Pty Ltd. (1)

C3 Research Associates (1)

act001 (1)

act001 + pembrolizumab (1)

drug (1)

Industry (1)

Interventional (1)

recurrent glioblastoma multiforme(gbm)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Nov 12, 2021